K Pharma,Inc. (TYO:4896)
Japan flag Japan · Delayed Price · Currency is JPY
675.00
-11.00 (-1.60%)
Nov 18, 2026, 10:13 AM JST

K Pharma,Inc. Statistics

Total Valuation

K Pharma,Inc. has a market cap or net worth of JPY 7.85 billion. The enterprise value is 7.44 billion.

Market Cap7.85B
Enterprise Value 7.44B

Important Dates

The last earnings date was Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

K Pharma,Inc. has 11.62 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class 11.62M
Shares Outstanding 11.62M
Shares Change (YoY) +0.11%
Shares Change (QoQ) -0.00%
Owned by Insiders (%) 40.90%
Owned by Institutions (%) 4.88%
Float 1.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 19.03
P/TBV Ratio 19.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.53, with a Debt / Equity ratio of 3.88.

Current Ratio 13.53
Quick Ratio 12.66
Debt / Equity 3.88
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.77

Financial Efficiency

Return on equity (ROE) is -116.19% and return on invested capital (ROIC) is -34.99%.

Return on Equity (ROE) -116.19%
Return on Assets (ROA) -32.38%
Return on Invested Capital (ROIC) -34.99%
Return on Capital Employed (ROCE) -49.01%
Weighted Average Cost of Capital (WACC) 5.98%
Revenue Per Employee n/a
Profits Per Employee -57.95M
Employee Count20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, K Pharma,Inc. has paid 2.00 million in taxes.

Income Tax 2.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.94% in the last 52 weeks. The beta is 0.48, so K Pharma,Inc.'s price volatility has been lower than the market average.

Beta (5Y) 0.48
52-Week Price Change +3.94%
50-Day Moving Average 744.52
200-Day Moving Average 740.32
Relative Strength Index (RSI) 46.83
Average Volume (20 Days) 27,895

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.01B
Pretax Income -1.16B
Net Income -1.16B
EBITDA n/a
EBIT -1.01B
Earnings Per Share (EPS) -99.76
Full Income Statement

Balance Sheet

The company has 2.03 billion in cash and 1.62 billion in debt, with a net cash position of 401.00 million or 34.50 per share.

Cash & Cash Equivalents 2.03B
Total Debt 1.62B
Net Cash 401.00M
Net Cash Per Share 34.50
Equity (Book Value) 419.00M
Book Value Per Share 36.05
Working Capital 2.01B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.01 billion and capital expenditures -34.00 million, giving a free cash flow of -1.05 billion.

Operating Cash Flow -1.01B
Capital Expenditures -34.00M
Depreciation & Amortization n/a
Net Borrowing 1.63B
Free Cash Flow -1.05B
FCF Per Share -90.08
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

K Pharma,Inc. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.11%
Shareholder Yield -0.11%
Earnings Yield -14.78%
FCF Yield -13.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1